Purple Biotech (PPBT) announced the appointment of Shai Lankry as its CFO. Prior to joining Purple Biotech, Mr. Lankry supported several companies as a strategic fractional CFO through his firm, LS Consulting Services.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPBT:
- Purple Biotech Unveils Strategic Advancements in Oncology Therapies
- Purple Biotech Unveils Promising Phase 2 Results for CM24 in Pancreatic Cancer
- Purple Biotech announces significant efficacy results from Phase 2 CM24 study
- Purple Biotech Announces Promising NT219 Data for Cancer Treatment
- Purple Biotech reports NT219 data at AACR meeting